🇺🇸 FDA
Pipeline program

Solution for Injection, subcutaneous Use, IMCIVREE 10 mg/ml solution for injection

RM-493-035

Phase 3 small_molecule active

Quick answer

Solution for Injection, subcutaneous Use, IMCIVREE 10 mg/ml solution for injection for Improper function of certain messenger materials in the body that control body weight and hunger in people is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Improper function of certain messenger materials in the body that control body weight and hunger in people
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials